Posts by Melissa S. Putman, MD
Continuous Glucose Monitoring Shows Promise for Diagnosis of Cystic Fibrosis–Related Diabetes
Melissa S. Putman, MD, and colleagues found measures of hyperglycemia and glycemic variability provided by continuous glucose monitors were superior to hemoglobin A1c in distinguishing between patients with cystic fibrosis (CF) who did and did not have CF-related diabetes.
Review: Use of Diabetes Technology by Patients With Cystic Fibrosis
Melissa S. Putman, MD, Jordan S. Sherwood, MD, and colleagues give practical tips for how patients with cystic fibrosis–related diabetes can make the best use of continuous glucose monitors, insulin pumps and automated insulin delivery systems.
Ivacaftor Improves Skeletal Outcomes in Patients with Cystic Fibrosis
In the first prospective study of its kind, a team led by Massachusetts General Hopsital found evidence that ivacaftor improves bone density and microarchitecture in children and adults with cystic fibrosis who have the G551D-CFTR mutation.
Dr. Melissa Putman is a dual-trained endocrinologist in adult and pediatric Endocrinology. Her interests include pediatric bone health, cystic fibrosis related bone disease, the prevention of adult endocrine complications of childhood diseases, and optimizing patient transitions from pediatric to adult care.